Fidelity Investments’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.9M | Sell |
|
|||||
|
2025
Q1 | $15.3M | Sell |
|
|||||
|
2024
Q4 | $26.2M | Buy |
|
|||||
|
2024
Q3 | $26.5M | Sell |
|
|||||
|
2024
Q2 | $94.6M | Sell |
|
|||||
|
2024
Q1 | $126M | Buy |
|
|||||
|
2023
Q4 | $89.7M | Sell |
|
|||||
|
2023
Q3 | $177M | Buy |
|
|||||
|
2023
Q2 | $188M | Buy |
|
|||||
|
2023
Q1 | $149M | Buy |
|
|||||
|
2022
Q4 | $121M | Sell |
|
|||||
|
2022
Q3 | $146M | Sell |
|
|||||
|
2022
Q2 | $326M | Sell |
|
|||||
|
2022
Q1 | $678M | Sell |
|
|||||
|
2021
Q4 | $1.04B | Sell |
|
|||||
|
2021
Q3 | $1.17B | Buy |
|
|||||
|
2021
Q2 | $946M | Buy |
|
|||||
|
2021
Q1 | $589M | Buy |
|
|||||
|
2020
Q4 | $451M | Buy |
|
|||||
|
2020
Q3 | $404M | Sell |
|
|||||
|
2020
Q2 | $339M | Buy |
|
|||||
|
2020
Q1 | $208M | Sell |
|
|||||
|
2019
Q4 | $292M | Buy |
|
|||||
|
2019
Q3 | $206M | Sell |
|
|||||
|
2019
Q2 | $226M | Sell |
|
|||||
|
2019
Q1 | $243M | Sell |
|
|||||
|
2018
Q4 | $204M | Sell |
|
|||||
|
2018
Q3 | $252M | Buy |
|
|||||
|
2018
Q2 | $138M | Sell |
|
|||||
|
2018
Q1 | $321M | Buy |
|
|||||
|
2017
Q4 | $328M | Buy |
|
|||||
|
2017
Q3 | $319M | Sell |
|
|||||
|
2017
Q2 | $311M | Buy |
|
|||||
|
2017
Q1 | $224M | Buy |
|
|||||
|
2016
Q4 | $136M | Sell |
|
|||||
|
2016
Q3 | $191M | Buy |
|
|||||
|
2016
Q2 | $178M | Buy |
|
|||||
|
2016
Q1 | $137M | Sell |
|
|||||
|
2015
Q4 | $150M | Sell |
|
|||||
|
2015
Q3 | $165M | Buy |
|
|||||
|
2015
Q2 | $169M | Buy |
|
|||||
|
2015
Q1 | $175M | Buy |
|
|||||
|
2014
Q4 | $76.6M | Sell |
|
|||||
|
2014
Q3 | $77.7M | Sell |
|
|||||
|
2014
Q2 | $82.3M | Buy |
|
|||||
|
2014
Q1 | $91M | Buy |
|
|||||
|
2013
Q4 | $47.9M | Buy |
|
|||||
|
2013
Q3 | $41.4M | Sell |
|
|||||
|
2013
Q2 | $41.8M | Buy |
|